Main Menu

Functional Genomics Team 

Dr Rachael Natrajan’s team investigates ways to translate the molecular pathology profiles of therapy resistant breast cancers into improved patient outcomes, through identification of new biomarkers and treatment strategies.

Team leader

Dr Rachael Natrajan

Dr Rachael Natrajan

Dr Rachael Natrajan is researching the ways in which different subgroups of breast cancer can be characterised through genetic analysis of the tumour. By improving this understanding, it is hoped that new treatments can be developed for specific breast cancer subtypes.

ORCID 0000-0002-9987-2946

Team members

Philip Bland

Postdoctoral Training Fellow

Amy Gibson

Scientific Officer

Ioanna Mavroammatis

Postdoctoral Training Fellow

Abigail Read

PhD student